Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.Earlier this month, Dandelion Health announced the launch of the first artificial intelligence (AI) database specifically aimed at bolstering research for GLP-1 drugs, giving trial sponsors unprecedented insights […]
